Skip to main content
Top

Clinical & Experimental Metastasis

Issue 7/2018

Content (12 Articles)

Commentary

Cost-effectiveness of Linac-based single-isocenter non-coplanar technique (HyperArcTM) for brain metastases radiosurgery

Filippo Alongi, Alba Fiorentino, Ruggero Ruggieri, Francesco Ricchetti, Patrick Kupelian

Research Paper

Short-course regimen of palliative radiotherapy in complicated bone metastases: a phase i–ii study (SHARON Project)

Jenny Capuccini, Gabriella Macchia, Eleonora Farina, Milly Buwenge, Domenico Genovesi, Luciana Caravatta, Nam P. Nguyen, Silvia Cammelli, Savino Cilla, Tigeneh Wondemagegnhu, A. F. M. Kamal Uddin, Mostafà Aziz Sumon, Francesco Cellini, Vincenzo Valentini, Francesco Deodato, Alessio G. Morganti

Research Paper

Black race and distant recurrence after neoadjuvant or adjuvant chemotherapy in breast cancer

Jessica M. Pastoriza, George S. Karagiannis, Juan Lin, Sonali Lanjewar, David Entenberg, John S. Condeelis, Joseph A. Sparano, Xiaonan Xue, Thomas E. Rohan, Maja H. Oktay

Open Access Research Paper

Locoregional control and survival after lymph node SBRT in oligometastatic disease

Mauro Loi, Michael Frelinghuysen, Natalie Desiree Klass, Esther Oomen-De Hoop, Patrick Vincent Granton, Joachim Aerts, Cornelis Verhoef, Joost Nuyttens

Research Paper

Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal metastases of pancreas and biliary tract cancer

Philipp Horvath, Stefan Beckert, Florian Struller, Alfred Königsrainer, Marc André Reymond

Research Paper

Clinicopathological and immunohistochemical analysis of autoimmune regulator expression in patients with osteosarcoma

Kotaro Matsuda, Hiroaki Miyoshi, Mayuko Moritsubo, Koji Hiraoka, Tetsuya Hamada, Naoto Shiba, Koichi Ohshima

Research Paper

Chronic low dose ethanol induces an aggressive metastatic phenotype in TRAMP mice, which is counteracted by parthenolide

Katherine L. Morel, Rebecca J. Ormsby, Emma L. Solly, Linh N. K. Tran, Christopher J. Sweeney, Sonja Klebe, Nils Cordes, Pamela J. Sykes

Research Paper

The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity

Shiue-Wei Lai, Oluwaseun Adebayo Bamodu, Wen-Chiuan Tsai, Yi-Ming Chang, Wei-Hwa Lee, Chi-Tai Yeh, Tsu-Yi Chao

Research Paper

Platelet deficiency in Tpo−/− mice can both promote and suppress the metastasis of experimental breast tumors in an organ-specific manner

Wilko Thiele, Melanie Rothley, Arno Dimmler, Peter Bugert, Carla Salomó Coll, Jonathan P. Sleeman

Open Access Research Paper

Heterogeneous distribution of trastuzumab in HER2-positive xenografts and metastases: role of the tumor microenvironment

Jennifer Hazel Elizabeth Baker, Alastair Hugh Kyle, Stefan Alexander Reinsberg, Firas Moosvi, Haley Margaret Patrick, Jordan Cran, Katayoun Saatchi, Urs Häfeli, Andrew Ivor Minchinton

Research Paper

ESR1-promoter-methylation status in primary breast cancer and its corresponding metastases

Verena Kirn, Leonie Strake, Fabinshy Thangarajah, Lisa Richters, Hannah Eischeid, Ulrike Koitzsch, Margarete Odenthal, Jochen Fries

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine